The Effects of Tumor Facilitating Factor of B16 Melanoma on the Macrophage

This publication has 29 references indexed in Scilit:

• Immunosuppressive Factors From Mastocytoma Cells Cultured in Serum-Free Medium23
  JNCI Journal of the National Cancer Institute, 1980
• Increased Incidence of Tumor Takes to B16 Melanoma in C57BL/6J Mice Injected with B16 Products
  Journal of Investigative Dermatology, 1980
• Suppression of T cell-mediated immunity by tumor cells: Immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors
  International Journal of Cancer, 1979
• Host Control of Tumor Growth
  Science, 1977
• Effects of Murine Tumors on Delayed Hypersensitivity to Dinitrochlorobenzene. I. Description of Anergy Caused by Transplanted Tumors
  JNCI Journal of the National Cancer Institute, 1976
• DISCUSSION PAPER: DUAL EFFECTS OF TUMOR, ANTIGENS: INDUCTION OF TUMOR RESISTANCE, OR TUMOR GROWTH ENHANCEMENT*
  Annals of the New York Academy of Sciences, 1976
• The effects of plasma from guinea pigs with tumor on PHA stimulated lymphocyte cultures
  Cellular Immunology, 1976
• Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection.
  The Journal of Experimental Medicine, 1976
• Factor(s) from Ehrlich Ascites Cells Responsible for Delayed Rejection of Skin Allografts in Mice and Its Assay on Lymphocytes in Vitro
  Experimental Biology and Medicine, 1975
• Association of Anergy with an Immunosuppressive Peptide Fraction in the Serum of Patients with Cancer
  New England Journal of Medicine, 1974